Alkermes (ALKS) Depreciation and Depletion (2010 - 2013)
Alkermes' (ALKS) quarterly Depreciation and Depletion came in at $32.3 million in Q4 2013, up 779.86% on a QoQ basis from -$4.8 million in Q1 2012.
Alkermes (ALKS) Depreciation and Depletion (2010 - 2013) Analysis & Trends
Alkermes (ALKS) has 4 years of Depreciation and Depletion data on file, last reported at $32.3 million in Q4 2013.
- On a quarterly basis, Depreciation and Depletion changed N/A year-over-year to $32.3 million in Q4 2013; TTM through Dec 2013 was $50.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $31.1 million, up 13.5% from the prior year.
- Depreciation and Depletion for Q4 2013 stood at $32.3 million, up from -$4.8 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for ALKS reached as high as $32.3 million in Q4 2013 and fell as low as -$4.8 million in Q1 2012.
- Historically, Depreciation and Depletion has averaged $10.6 million across 4 years, with a median of $2.5 million in 2011.
- Across the five-year window, Depreciation and Depletion soared 871.79% in 2011 and plunged 290.8% in 2012, its largest moves.
- Year by year, Depreciation and Depletion stood at $2.1 million in 2010, then surged by 871.79% to $20.9 million in 2011, then plunged by 122.76% to -$4.8 million in 2012, then surged by 779.86% to $32.3 million in 2013.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $32.3 million in Q4 2013, -$4.8 million in Q1 2012, and $20.9 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 32.30 Mn |
| Dec 31, 2013 | 32.30 Mn |
| Mar 31, 2012 | -4.75 Mn |
| Mar 31, 2012 | -4.75 Mn |
| Dec 31, 2011 | 20.87 Mn |
| Dec 31, 2011 | 20.87 Mn |
| Mar 31, 2011 | 2.49 Mn |
| Mar 31, 2011 | 2.49 Mn |
| Dec 31, 2010 | 2.15 Mn |
| Dec 31, 2010 | 2.15 Mn |